leisure time -WSS

leisure time

author：entertainment 2025-10-06 14:55:56 - browse：797

The US Supreme Court silhouetted -- Abortion coverage from STAT — STEFANI REYNOLDS/AFP via Getty Images

WASHINGTON — The Supreme Court on Monday wrestled with a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.

The justices seemed by turns relucant to break up an exhaustively negotiated agreement, but also leery of somehow rewarding the Sacklers.

The agreement hammered out with state and local governments and victims would provide billions of dollars to combat the opioid epidemic. The Sacklers would contribute up to $6 billion and give up ownership of the company, but retain billions more. The company would emerge from bankruptcy as a different entity, with its profits used for treatment and prevention.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Eli Lilly’s Mounjaro succeeds in second weight

WSS

How to fix the rural physician shortage in the U.S.

Novo pauses ads for weight loss drug Wegovy amid demand

Eli Lilly’s Mounjaro succeeds in second weight

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

FDA approves first new drug developed for postpartum depression

A new study sees potential in DNA sequencing of infants

knowledge

leisure time

knowledge

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Leqembi, other new Alzheimer’s drugs require better biomarkers

Medical records are filled with copy

Novo pauses ads for weight loss drug Wegovy amid demand

Apple is now the first public company to be valued at $3 trillion

Timeline: Key moments in fight for gay rights

DIEP, the 'gold standard' of breast reconstruction, is under threat

Novo: Oral version of Ozempic leads to 15% weight loss

Walensky prepares to leave CDC — and Congress — behind

A new study sees potential in DNA sequencing of infants

focus

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Palantir health business leans on meeting customers’ needs

Bulgari apologizes to China for listing Taiwan as a country after online backlash

Biden administration plans revamp of organ transplant system

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

hotspot

focus

explore

Wikipedia